Company
Headquarters: Gothenburg, Sweden
Employees: 209
€699.0 Million
EUR as of July 1, 2025
US$825.4 Million
Company | Market Cap (USD) |
---|---|
Veeva Systems Inc. | $46.46 B |
GE HealthCare | $34.85 B |
Change Healthcare Inc. | $9.03 B |
M3, Inc. | $8.98 B |
Pro Medicus Limited | $8.96 B |
Company | Market Cap (USD) |
---|---|
Lilly | $699.59 B |
Johnson & Johnson | $374.29 B |
AbbVie | $336.94 B |
Novo Nordisk | $309.91 B |
UnitedHealth Group | $279.90 B |
Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based laparoscopic and endoscopic training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; and LapSim essence, a portable and ready-to-use VR simulator. The company also provides EndoSim system, an endoscopy simulator that delivers medical simulation training; TeamSim, a dynamic platform for inter-professional education development taking surgery simulation into the real world teamwork; Simball Box, which offers feedback on velocity with tutorial task videos showing a preferred approach; simbionix simulators; and robotic surgery simulators. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden.
Surgical Science Sweden AB has the following listings and related stock indices.
Stock: FSX: 4P41 wb_incandescent
Stock: OTC: SUSRF wb_incandescent